Israel Charo

37.1k total citations · 12 hit papers
162 papers, 29.4k citations indexed

About

Israel Charo is a scholar working on Immunology, Oncology and Immunology and Allergy. According to data from OpenAlex, Israel Charo has authored 162 papers receiving a total of 29.4k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Immunology, 88 papers in Oncology and 35 papers in Immunology and Allergy. Recurrent topics in Israel Charo's work include Chemokine receptors and signaling (80 papers), Cell Adhesion Molecules Research (33 papers) and Immune cells in cancer (27 papers). Israel Charo is often cited by papers focused on Chemokine receptors and signaling (80 papers), Cell Adhesion Molecules Research (33 papers) and Immune cells in cancer (27 papers). Israel Charo collaborates with scholars based in United States, Japan and United Kingdom. Israel Charo's co-authors include Richard M. Ransohoff, Jennifa Gosling, Landin Boring, Michael D. Cleary, David R. Phillips, Wendy Peters, Chia-Lin Tsou, Mark B. Taubman, Sarah Slaymaker and Christopher A. Haskell and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Israel Charo

160 papers receiving 28.8k citations

Hit Papers

The Many Roles of Chemokines and Chemokine Receptors i... 1994 2026 2004 2015 2006 1998 2000 2005 1997 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Israel Charo United States 90 14.9k 8.3k 6.2k 3.7k 3.6k 162 29.4k
Ghislain Opdenakker Belgium 91 9.4k 0.6× 8.6k 1.0× 9.5k 1.5× 2.5k 0.7× 3.4k 1.0× 512 30.1k
Silvano Sozzani Italy 95 25.7k 1.7× 12.6k 1.5× 10.6k 1.7× 4.2k 1.1× 3.2k 0.9× 314 41.1k
Stefan Rose‐John Germany 109 18.4k 1.2× 17.4k 2.1× 13.7k 2.2× 6.0k 1.6× 2.5k 0.7× 564 47.9k
Gwendalyn J. Randolph United States 86 21.0k 1.4× 6.4k 0.8× 8.7k 1.4× 3.9k 1.1× 1.6k 0.4× 184 33.4k
Barrett J. Rollins United States 71 10.8k 0.7× 8.0k 1.0× 6.0k 1.0× 2.3k 0.6× 2.2k 0.6× 126 23.0k
Craig Gérard United States 86 16.2k 1.1× 5.8k 0.7× 6.3k 1.0× 3.5k 1.0× 2.0k 0.6× 223 29.5k
Jordan S. Pober United States 97 15.7k 1.1× 4.3k 0.5× 12.0k 1.9× 2.9k 0.8× 6.3k 1.8× 362 37.0k
Paul P. Tak Netherlands 96 11.8k 0.8× 4.5k 0.5× 8.6k 1.4× 2.0k 0.5× 1.2k 0.3× 459 33.5k
Sérgio A. Lira United States 75 14.8k 1.0× 5.9k 0.7× 6.2k 1.0× 2.6k 0.7× 987 0.3× 190 27.4k
George Kollias Greece 89 10.9k 0.7× 5.6k 0.7× 12.1k 2.0× 2.1k 0.6× 1.2k 0.3× 306 30.3k

Countries citing papers authored by Israel Charo

Since Specialization
Citations

This map shows the geographic impact of Israel Charo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Israel Charo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Israel Charo more than expected).

Fields of papers citing papers by Israel Charo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Israel Charo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Israel Charo. The network helps show where Israel Charo may publish in the future.

Co-authorship network of co-authors of Israel Charo

This figure shows the co-authorship network connecting the top 25 collaborators of Israel Charo. A scholar is included among the top collaborators of Israel Charo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Israel Charo. Israel Charo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miao, Zhenhua, Linda Ertl, Dale Newland, et al.. (2018). CCR2 antagonism leads to marked reduction in proteinuria and glomerular injury in murine models of focal segmental glomerulosclerosis (FSGS). PLoS ONE. 13(3). e0192405–e0192405. 8 indexed citations
2.
Dal-Secco, Daniela, Jing Wang, Zhutian Zeng, et al.. (2015). A dynamic spectrum of monocytes arising from the in situ reprogramming of CCR2+ monocytes at a site of sterile injury. The Journal of Experimental Medicine. 212(4). 447–456. 350 indexed citations
3.
Hsieh, Christine L., Eréne C. Niemi, Chih Cheng Lee, et al.. (2014). CCR2 Deficiency Impairs Macrophage Infiltration and Improves Cognitive Function after Traumatic Brain Injury. Journal of Neurotrauma. 31(20). 1677–1688. 138 indexed citations
4.
Sullivan, Timothy J., Zhenhua Miao, Daniel J. Dairaghi, et al.. (2013). CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice. American Journal of Physiology-Renal Physiology. 305(9). F1288–F1297. 76 indexed citations
5.
Varvel, Nicholas H., Stefan Grathwohl, Frank Baumann, et al.. (2012). Microglial repopulation model reveals a robust homeostatic process for replacing CNS myeloid cells. Proceedings of the National Academy of Sciences. 109(44). 18150–18155. 203 indexed citations
6.
Jia, Ting, Natalya V. Serbina, Katharina Brandl, et al.. (2008). Additive Roles for MCP-1 and MCP-3 in CCR2-Mediated Recruitment of Inflammatory Monocytes during Listeria monocytogenes Infection. The Journal of Immunology. 180(10). 6846–6853. 194 indexed citations
7.
Bennett, Jami, Adam Elhofy, Israel Charo, et al.. (2007). CCR2 Regulates Development of Theiler's Murine Encephalomyelitis Virus-Induced Demyelinating Disease. Viral Immunology. 20(1). 19–33. 22 indexed citations
8.
Green, Simone R., Ki Hoon Han, Yiming Chen, et al.. (2006). The CC Chemokine MCP-1 Stimulates Surface Expression of CX3CR1 and Enhances the Adhesion of Monocytes to Fractalkine/CX3CL1 via p38 MAPK. The Journal of Immunology. 176(12). 7412–7420. 54 indexed citations
9.
Weisberg, Stuart P., Deborah Hunter, Reid Huber, et al.. (2005). CCR2 modulates inflammatory and metabolic effects of high-fat feeding. Journal of Clinical Investigation. 116(1). 115–124. 1226 indexed citations breakdown →
10.
Chiu, Bo‐Chin, Christine M. Freeman, Valerie R. Stolberg, et al.. (2004). Impaired Lung Dendritic Cell Activation in CCR2 Knockout Mice. American Journal Of Pathology. 165(4). 1199–1209. 37 indexed citations
11.
Peters, Wendy, Jason G. Cyster, Matthias Mack, et al.. (2004). CCR2-Dependent Trafficking of F4/80dim Macrophages and CD11cdim/intermediate Dendritic Cells Is Crucial for T Cell Recruitment to Lungs Infected with Mycobacterium tuberculosis. The Journal of Immunology. 172(12). 7647–7653. 96 indexed citations
12.
Abdi, Reza, Terry K. Means, Toshiro Ito, et al.. (2004). Differential Role of CCR2 in Islet and Heart Allograft Rejection: Tissue Specificity of Chemokine/Chemokine Receptor Function In Vivo. The Journal of Immunology. 172(2). 767–775. 68 indexed citations
13.
Peters, Wendy & Israel Charo. (2001). Involvement of chemokine receptor 2 and its ligand, monocyte chemoattractant protein-1, in the development of atherosclerosis: lessons from knockout mice. Current Opinion in Lipidology. 12(2). 175–180. 102 indexed citations
14.
Belperio, John A., Michael P. Keane, Marie D. Burdick, et al.. (2001). Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome. Journal of Clinical Investigation. 108(4). 547–556. 195 indexed citations
15.
Blease, Kate, Borna Mehrad, Theodore J. Standiford, et al.. (2000). Enhanced Pulmonary Allergic Responses to Aspergillus in CCR2−/− Mice. The Journal of Immunology. 165(5). 2603–2611. 122 indexed citations
16.
Gosling, Jennifa, Sarah Slaymaker, Long Gu, et al.. (1999). MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. Journal of Clinical Investigation. 103(6). 773–778. 552 indexed citations breakdown →
17.
Charo, Israel. (1999). CCR2: From Cloning to the Creation of Knockout Mice. PubMed. 72. 30–41. 39 indexed citations
18.
Chensue, Stephen W., Landin Boring, Kelly Warmington, et al.. (1998). Effect of C-C Chemokine Receptor 2 (CCR2)knockout on schistosomal egg antigen-elicited granuloma formation and the regional lymphoid response. The FASEB Journal. 12(5). 1 indexed citations
19.
Phillips, David R., et al.. (1989). Synthesis and expression of the fibroblast fibronectin receptor in human monocytes.. Journal of Clinical Investigation. 84(1). 366–370. 46 indexed citations
20.
Feinman, Richard D., et al.. (1977). The lumi-aggregometer: a new instrument for simultaneous measurement of secretion and aggregation by platelets.. PubMed. 90(1). 125–9. 166 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026